Background. The influence of the Bsm1 polymorphism of the vitamin D receptor (VDR) gene on mineral and bone disorders in chronic kidney disease (CKD) is still under discussion. The aim of this study was to analyse the relationship between VDR polymorphism, bone mineral density (BMD), biochemical bone markers and clinical factors in women on peritoneal dialysis (PD) and haemodialysis (HD). Methods. In a cross-sectional study, 197 women (42 ± 10 years; 25% with diabetes mellitus (DM); body mass index (BMI) 25.26 ± 4.77 kg/m 2 ) treated by PD (72%) or HD (28%) underwent measurements of BMD (measured at the calcaneus by quantitative ultrasound; expressed as Tand Z-scores) and plasma total calcium (tCa), intact parathyroid hormone 1-84 (iPTH), phosphorus, albumin, glucose, osteoprotegerin (OPG), fetuin-A, intact osteocalcin-49 and N-MID fragment 1-43 aa (N-MID osteocalcin) N-terminal propeptide of type 1 procollagen (PINP) and C-terminal telopeptide-β aspartic acid (BCL). DNA was extracted from peripheral blood. PCR products were digested with Bsm1 to analyse VDR polymorphism. Results. The Z-score of BMD was −1.1 ± 1.03. According to the values of osteopenia (T-score = −1.0), patients with higher BMD were younger, had lower frequency of amenorrhoea and diabetes and had higher serum creatinine and fetuin levels as well as lower levels of PINP. In a stepwise multivariate logistics analysis, osteopenia was associated with presence of genotype BB+Bb (OR = 3.26, P ≤ 0.003) and age (OR = 0.95, P = 0.050). According to the B allele, bb: n = 126 (64%) and BB+Bb: n = 71(36%), group bb had significantly higher mean Z-scores (−0.97 ± 1.0 vs −1.3±0.92; P ≤ 0.021). Conclusions. The high frequency of osteopenia observed in female CKD patients on dialysis is associated with age and genetic predisposition as revealed by its association to the Bsm1 VDR polymorphism.
Introduction
An inverse relationship between bone mineral density (BMD) and renal function is shown in several studies. Patients in advanced stages of chronic kidney disease (CKD) have a reduction in BMD and, after initiating dialysis, the reduction in BMD is even more important [1] [2] [3] [4] . In haemodialysis (HD) patients with hip or spine fractures, lower values of radial BMD were found when compared with those of patients without fractures, suggesting that BMD plays a role as risk factor for hip fractures in dialysis patients just as it does in the non-uraemic population [5, 6] .
The risk factors for a reduction of BMD, as well as hip fractures, in patients on dialysis are similar to those of the non-uraemic population and include, for example, age and gender [5] [6] [7] [8] . In a non-uraemic population, it has been reported that BMD can also be under the influence of genetic factors. Among the genetic factors, one of the most studied is the polymorphism of the vitamin D receptor (VDR). Analysis of the DNA fragments (restriction fragments length polymorphisms, RFLP) generated by the Bsm1 enzyme has demonstrated that the genotype bb (G/A (rs1544410) in intron 8 [9] ) is associated with high BMD values. In patients with end stage renal disease (ESRD), studies of the association between BMD and the polymorphism of VDR are scarce and often contradictory. The bb genotype was associated with higher BMD in a crosssectional study of women on dialysis [10] , but this is not a consistent finding [11] , although during the follow-up, patients with the BB genotype lost more bone mass [11, 12] . In two studies in patients with renal transplant, contradictory results have been reported, as lower BMD values or faster decline of BMD corresponded to the bb genotype [13, 14] .
The lack of consistency in the association between BMD and the polymorphism of VDR can most likely be explained by differences in confounding variables. Biochemical and hormonal factors such as the rate of bone turnover and alterations in calcium, phosphorus and PTH might be important. Other clinical factors or those related to treatment might also play a significant role. Non-uraemic diabetic patients have greater BMD than non-diabetics [15, 16] , and this could be a confusing factor if the proportion of diabetics is high in the population under study [17] . The dialysis modality also has a potential effect. The frequency of hypercalcaemia and low bone turnover in peritoneal dialysis (PD) [18] could be another confusing factor in the association of BMD with the polymorphism of VDR.
The objective of this study was to analyse the association between BMD and the Bsm1 polymorphism of VDR, as well as the potential impact of clinical factors (such as age, presence of diabetes and/or the dialysis modality) and laboratory factors (such as iPTH, calcium and phosphate) on BMD in women on PD and HD.
Materials and methods

Design
A cross-sectional study was performed in female dialysis patients recruited from eight hospitals in Mexico City with chronic dialysis programmes. All of the hospitals belong to the Instituto Mexicano del Seguro Social. The research and ethics committee from each hospital approved the protocol and all the patients gave their written informed consent before enrolment in the study.
Patients
All the patients were adults of Mexican ethnicity and were on a chronic dialysis programme for at least 3 months. Patients were free of infections or acute complications for at least 1 month prior to study entry. There was no selection by primary renal disease and vitamin D therapy. Patients with parathyroidectomy, steroid therapy or positive serology for human immunodeficience virus (HIV) and hepatitis B were not included. HD patients were treated according to a 4-h, three-times-a-week dialysis schedule with bicarbonate-buffered solutions containing 3.0 mEq/L of calcium (Fresenius Medical Care, Lexington MA.USA). PD patients received four exchanges with 2-L bags of conventional dialysis solution containing 3.5 mEq/L of calcium (Dianeal, Baxter México, México). Patients were considered to be on calcitriol treatment if they had been receiving it for more than 1 month. When used, calcitriol was administered in doses of 0.25 to 0.75 µg/day. CaCO 3 was prescribed on average 2.5 g/day (range 0 to 6 g/ day). Twenty-eight healthy Mexican women along with 66 Mexican women from a previous study [19] were used as genetic controls.
Procedures
All the patients were called for a clinical review and their demographic and clinical data were recorded. Gynaecological and obstetric backgrounds were compiled (number of children, time of breastfeeding and amenorrhoea) as well as medical history for renal disease (original disease, time and modalities of dialysis, diabetic status, history of fractures, symptoms of bone disease and use of calcitriol, calcium carbonate and aluminium prescription), along with factors related to calcium metabolism, such as ingestion of coffee, soft drinks, alcohol and tobacco consumption.
Amenorrhoea was defined as the absence of menstruation exceeding a 6-month period. Walking difficulty, fractures and bone pain were classified as present or absent by interview. After an overnight fast, a blood sample was drawn from an antecubital vein without stasis. In HD patients, the blood sample was taken on a day free of HD in conjunction with the time of the BMD test of calcaneus (see below). The blood sample was centrifuged and the plasma stored at −70°C until assayed. Inter-and intra-assay coefficient of variation (CV) for PO 4 and tCa were 0.9 and 1.4% and 1.0 and 1.5%, respectively. For iPTH, OT, PINP and BCL, 2.0 and 3.2%, 1.2 and 4.0%, 2.3 and 3.0% and 3.8 and 3.1%, respectively. For OPG and fetuin, 1.0 and 4.0% and 1.4 and 3.5%, respectively.
Bone mineral density
BMD of the calcaneus was determined by quantitative ultrasound (QUS) on a Sahara Clinical Bone Sonometer (Hologic, Waltham, MA, USA). The primary parameters measured with QUS are broadband ultrasound attenuation (BUA; in decibels per megahertz) and speed of sound (SOS; in metres per second) of an ultrasound beam passing through the calcaneus. This value has previously been correlated with X-ray BMD of calcaneus measurements in 2208 Caucasian female subjects [20, 21] and can, therefore, be expressed as estimated heel BMD in grams per square centimetre. The output is also expressed as a T-score, which is defined as the difference in patient results from the mean results obtained in a young adult population of females, expressed in units of standard deviation from the young adult population. Z-scores (BMD value in relation to agematched controls) were assessed manually by entering data into preprinted patient report forms supplied to the units. The equipment was calibrated at the beginning of the measurements and during the procedure using a phantom. The CV in 1 day was 1.2% and 2% in 3 days. International values have not been defined for osteoporosis with ultrasound equipment; however, in a recently published meta-analysis [22] , the cutoff point for osteopenia was considered to be −1.0 in the calcaneus of healthy women.
Genotyping VDR alleles were typed by using a PCR-based assay developed to ascertain the presence of a polymorphic Bsm1 restriction site located in the intron eight to the 3′ untranslated region (UTR) of the VDR gene. DNA was extracted from total blood (QIAamp DNA Blood Midi Kit, Qiagen, Valencia, CA, USA). A selected fragment of 740 bp was amplified by PCR with primer 1, 5′-CAACCAAGACTACAAGTACCGCGTCAGT-GA-3′, and primer 2, 5′-AACCAGCGGGAAGAGGTCAAGGG-3′ [23] . The reactions were performed in a DNA thermocycler (Biometra 210, Gottingen, Germany) and consisted of 95°C for 30 s, 70°C for 45 s and 72°C for 1 min for 30 cycles. This product was amplified again with primer 3, 5′-AGTGTGCAGGCGATTCGTAG-3′, and primer 4, 5′-ATAGGCAGAACCATCTCTCAG-3′ [23] and consisted of 94, 62 and 72°C for 1 min each, for 30 cycles, to obtain the 190-bp fraction. Two hundred nanograms of the PCR product were digested with 5 U Bsm1 at 65°C for 3 h (New England BioLabs, USA). The digestion products were separated by electrophoresis in 5% acrylamide gel and stained with ethidium bromide (0.5 µg/ml).The alleles were labelled as previously described: uppercase means absence and lowercase means presence of the restriction site. The bands were analysed with Gel Analysis Software Ver. 3.0404.1997 (Gene Tools, Syngene, Cambridge, UK). In the BB homozygote, one 190-bp band was present; in bb, a 110-bp and a 77-bp band were present and in the Bb heterozygote, all of the three bands were present. Some of these were sequenced at random to verify the polymorphism.
Statistical analysis
All variables were expressed as mean ± SD or as median and range, unless otherwise indicated. Statistical significance was set at the level of P ≤ A logistic regression analysis was used to study variables associated with BMD considering as co-variables those variables which showed significant statistical differences in the univariate analysis by T-score of BMD.
The T-score of BMD (cut-off of −1.0) was considered as a nominal dependent variable. Statistical computations were carried out using SAS, version 9.2 (SAS Institute, Cary, NC, USA).
Results
One hundred and ninety-seven patients were included in the study. The causes of CKD were diabetic nephropathy in 44 (22.3%), hypertension in 25 (12.7%), polycystic kidney disease in 16 (8.1%), glomerulonephritis in 13 (6.6%), lupus in 9 (4.6%), pyelonephritis in 3 (1.5%), obstructive uropathy in 4 (2.0%) and other or unknown causes in 83 (42.1%) patients. One hundred and forty-one women were treated by PD (71.6 %), and 56 patients (28.4%) were on HD. Demographic and clinical data are shown in Table 1 .
T-score values of BMD in the range of osteopenia (<−1.0) were found in 64% of the patients, and 10% had BMD in the osteoporosis range (T-score < −2.5). Patients were classified into two groups according to the values of the T-score. The selected cut-off point was −1.0, and this point coincides with the limit of the lower tertile of the whole group. Table 2 shows the univariate analysis of clinical and biochemical data with that criteria. Patients with higher BMD (T-score > −1.0) were younger, had lower frequency of amenorrhoea and diabetes mellitus (DM) and had higher serum creatinine and fetuin levels and bb genotype, as well as lower levels of PINP. We did not find differences between DP and HD in the T-score or BMD. Furthermore, we did not find differences in other variables that could exert an effect on DP or HD such as weight, BMI, PO 4 , iPTH, Ca or Ca × PO 4 . Differences between DM and non-DM for Z-score was P < 0.05, BMD was 0.006 and T-score P < 0.004.
Distribution of genotypes was similar among patients and controls. Frequencies of bb, Bb and BB genotypes were 64.2, 30.5 and 5.3% in patients and 64.2, 32.1 and 3.7% in controls, respectively. The Hardy-Weinberg equilibrium in patients and controls was preserved for the Bsm1 polymorphism. Demographic and clinical data of patients classified by Bsm1 polymorphism are seen in Table 3 . Patients with bb genotype had higher values of BMD when compared with those with the BB+Bb genotype (0.45 ± 0.12 vs 0.40 ± 0.10 g/cm 2 ; P < 0.016), Zscore (−0.97 ± 1.0 vs −1.3 ± 0.92; P < 0.021), T-score (−1.14 ± 1.0 vs −1.48 ± 0.97; P < 0.032) and BMI lower (24.7 ± 4.18 vs 26.6 ± 5.5; P < 0.015).
In order to find risk factors for the lower values of BMD, a logistic regression analysis with T-score as nominal variable and those variables which showed significant statistical differences in the univariate analysis by BMD Tscore such as age, amenorrhoea, diabetes, creatinine, PINP, fetuin and polymorphism Bsm1. Dialysis modality was introduced in the logistic regression; it had no statistical significance (Table 4) . Bsm1 polymorphism and age were the only significant independent risk factors for low BMD. Thus, the BB+Bb genotype was associated with an increased risk for low BMD T-score.
To understand how the different markers of bone metabolism were related, a multiple correlation of T-score (as continuous variable) was constructed with those bone metabolism-related variables controlling by age, diabetes and VDR gene, biochemical bone markers and BMD in Mexican womendialysis modality, as shown in Table 5 . There was a positive correlation between T-score of BMD and fetuin, tCa and Ca × PO 4 levels and inverse correlations with BCL and PINP. We found a statistically significant association between PTH and PINP, BCL and OT and also between PINP, BCL and OT.
Discussion
The main findings of this study are that BMD evaluated by QUS in the calcaneus and expressed as T-score have values in the osteopenic range in two-thirds and in the osteoporotic range in a tenth of the analysed group of women under dialysis treatment. Older age, diabetes, longer period with amenorrhoea, lower values of creatinine, fetuin, Ca × PO 4 product and high values of PINP, as well as BB+Bb genotype of the Bsm1 polymorphism of the VDR were associated with lower values of BMD, but only age and VDR genotype were significant as independent risk factors. Low BMD and high frequency of osteoporosis and hip fractures have been reported in CKD patients, and there is an inverse relationship between BMD and glomerular filtration rate [1] [2] [3] [4] ; in this regard, our data, showing a high prevalence of osteopenia and osteoporosis, confirm previous observations. Sixty-four percent of the analysed patients had BMD T-score in the osteopenic range which is higher than in non-uraemic Mexican subjects in whom osteopenia was reported to be present in 24-27%. On the other hand, the prevalence of osteoporosis of 10% was similar to values of 6-9% reported for non-uraemic Mexican women [24, 25] .
BMD values have a widely recognized association with some particular variables, such as age and amenorrhoea [26, 27] . The women of this study may seem young. However, it is important to point out that the Mexican population is younger than most of the developed countries. Women older than 65 years account for <2.9% of the total population (National Institute of Geography and Statistics, http://www:inegi.gob.mx). The age of women of this study is very close to the age of women from other studies previously reported with PD Mexican populations [28, 29] . In spite of the perceived differences, age was clearly different between high and low BMD T-score groups. Amenorrhoea was more frequent in low T-score women, but did not have an impact as an independent risk factor in the logistic regression analysis.
The impact of diabetes on BMD has been analysed in several reports. Patients with type 1 diabetes often have low values of BMD compared with non-diabetic subjects [30] . On the other hand, in type 2 diabetics, BMD is usually higher than in type 1 diabetics [15, 16] . While low BMD is consistently observed in type 1 diabetes, the relationship is less clear in type 2 diabetes, with some studies reporting modestly increased or unchanged BMD [31] . These data seem to be in conflict with the higher frequency of hip fractures in diabetic women than in non-diabetic controls which suggest that, in spite of higher BMD, diabetic bones are more fragile [32] . Among the group of women herein reported, 25% had diabetes; all of whom had type 2 diabetes. We found lower BMD T-scores in the diabetic patients. This suggests that CKD and/or dialysis had a stronger effect than the previous vintage of diabetes.
Some previous reports have shown differences in BMD by dialysis modality, suggesting that BMD is better preserved in PD than HD patients [33, 34] and that calcium content of dialysis solutions might have a role [35, 36] . We were not able to find such a difference between the two dialysis modalities, nor in tCa × PO 4 , Ca, PO 4 , iPTH, calcitriol and CaCO 3 intake, BMI and body weight. When dialysis modality was introduced in the logistic regression because of a potential interaction with other variables of bone metabolism, it had no statistical significance.
The observed positive relation between low serum creatinine levels and osteopenia probably reflects an impact of malnutrition/wasting on BMD as in the pre-dialysis serum creatinine level is in part determined by both the dietary meat intake and the somatic (skeletal) muscle mass.
There was a positive correlation between T-score of BMD and fetuin (Table 4) . Relation of fetuin with BMD has been previously described also in older women and non-uraemic patients with atherosclerosis [37, 38] ; however, the meaning of this relation in CKD patients is not known. BMD showed inverse association with markers of the synthesis and degradation of type 1 collagen deposition in bone turnover, PINP and BCL, probably due to its close relationship with collagen removal from bone as was described before [39] [40] [41] . We found an association between BMD and Ca × PO 4 product but not with iPTH levels. Low BMD has been previously related to the condition with high iPTH levels [42, 43] ; however, a lack of relationship [44] and even a direct correlation has also been reported [45] . In our data, the value of all these factors in predicting BMD declined in the logistic analysis. Correlations in crosssectional studies need careful interpretation since serum levels of biochemical variables may vary over time and the current levels may not reflect a stable trend. The association between the VDR gene polymorphism and BMD has been studied in populations with a broad spectrum of ethnicities, age and clinical conditions. In most of them, the bb genotype has been found to be associated with higher BMD values [9] , while in Mexican [19] and in Mexican-American women [46] , the bb genotype was associated with lower values of BMD. In line with the main body of information, the bb genotype was associated with higher BMD in a cross-sectional study of women on dialysis [10] . In two other non-interventional studies in women on HD, VDR polymorphism was unrelated to BMD at the basal evaluation, although during the follow-up, patients with the BB genotype lost more bone mass [11, 12] . Our data support the association of the bb genotype with a better preservation of BMD in CKD women independently of dialysis modality, diabetic status and PTH levels. The difference with other studies in non-uraemic women of Mexican origin may be due to the specific effects of CKD and dialysis therapy on mineral and bone metabolism. Parathyroid function and sensitivity of the VDR to calcitriol has been suggested as the link between VDR polymorphism and BMD. Patients with the bb genotype have higher calcium and iPTH serum levels [47] [48] [49] [50] and calcitriol bolus exerted a more effective suppression of iPTH in patients with the BB genotype [51] . However, in cell cultures, calcitriol had similar effects in the cell from all genotypes [52] , suggesting that the effect of VDR polymorphism on BMD has different or alternative mechanisms to that of iPTH levels. It is difficult to establish a link between the presence of the Bsm1 alleles and differences in VDR expression or functionality since they are in the UTR of the DNA. But studies with minigenes in kidney and bone cell liners and subjects with primary hyperparathyroidism have shown that allele differences in the 3′ UTR of the VDR gene are related to the levels of mRNA of VDR and VDR; the baT haplotype of the VDR gene was associated with reduced VDR expression or stability of its mRNA and VDR protein compared with BAt [23, 53] . Also, there are studies where no relation has been found between haplotypes and expression of m RNA [54] .
Therefore, we cannot exclude the possibility that other 3′ UTR polymorphisms, detected as Apa (rs17879735) and TAq 1 (rs1788009) RFLP, in linkage disequilibrium with Bsm1 in VDR would explain the association observed with BMD and Bsm1. Actually, there is no data available on linkage disequilibrium between Bsm1 polymorphism in Mexican populations. We can hypothesize that the bone tissue of the patients carrying bb may have somewhat more capacity for the expression of the VDR protein.
One other possible mechanism would be through the regulation of mRNA by means of microRNAs, which are small non-coding RNAs that regulate gene expression through translation repression or mRNA degradation. They act upon the 3′ UTR region, impeding translation of the mRNA, as is the case of microRNA (miR-125b) which regulates VDR, as has recently been found [55] .
Among the limitations of the study, it should be noted that, currently, dual energy x-ray absorptiometry (DEXA) is considered to be the reference method. However, QUS, which has a close relationship with DEXA, has demonstrated its usefulness in the evaluation of BMD in dialysis patients [56, 57] and has predictive value for hip fractures [21] . Furthermore, it has been mentioned that QUS measures not only bone mineralization, but also evaluates the quality of bone [21] . The results of this study contribute to a better understanding of factors involved in BMD changes in female CKD patients. Of the many factors analysed in our study, only age and the VDR gene predicted the BMD in calcaneus. Although they do not support changes in the current clinical practice, they may be a help in the pharmacogenetic approach to mineral derangements of CKD patients.
Conclusion
In summary, our results show a high frequency of osteopenia in female CKD patients treated by dialysis and that the presence of osteopenia is associated with age and genetic factors as revealed by its association to the Bsm1 VDR polymorphism.
